These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35950574)
1. Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder? Topuz RD; Gorgulu Y; Kyazim Uluturk M World J Biol Psychiatry; 2023 Apr; 24(4):314-320. PubMed ID: 35950574 [TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS. Cerbo AD Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106 [TBL] [Abstract][Full Text] [Related]
4. Plasma N-acylethanolamine and endocannabinoid levels in burning mouth syndrome: Potential role in disease pathogenesis. Barry A; O'Halloran KD; McKenna JP; McCreary C; Harhen B; Kerr DM; Finn DP; Downer EJ J Oral Pathol Med; 2018 Apr; 47(4):440-442. PubMed ID: 29436743 [TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid and perceived stress: Association analysis of endocannabinoid levels in hair versus levels in plasma and urine. Valdivieso Barba S; Kirschbaum C; Gao W Biol Psychol; 2023 Mar; 178():108541. PubMed ID: 36918140 [TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid levels in female-sexed individuals with diagnosed depression: a systematic review. McWhirter M; Bugarcic A; Steel A; Schloss J BMC Womens Health; 2024 Jun; 24(1):350. PubMed ID: 38886733 [TBL] [Abstract][Full Text] [Related]
7. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia]. Dakhlaoui O; Essafi I; Haffani F Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234 [TBL] [Abstract][Full Text] [Related]
8. Bipolarity in depressive patients without histories of diagnosis of bipolar disorder and the use of the Mood Disorder Questionnaire for detecting bipolarity. Kim B; Wang HR; Son JI; Kim CY; Joo YH Compr Psychiatry; 2008; 49(5):469-75. PubMed ID: 18702932 [TBL] [Abstract][Full Text] [Related]
9. Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity. Gebeh AK; Willets JM; Bari M; Hirst RA; Marczylo TH; Taylor AH; Maccarrone M; Konje JC J Clin Endocrinol Metab; 2013 Mar; 98(3):1226-34. PubMed ID: 23372171 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population. Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873 [TBL] [Abstract][Full Text] [Related]
11. Lower circulating endocannabinoid levels in children with autism spectrum disorder. Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J Mol Autism; 2019; 10():2. PubMed ID: 30728928 [TBL] [Abstract][Full Text] [Related]
12. Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. Fanelli F; Mezzullo M; Repaci A; Belluomo I; Ibarra Gasparini D; Di Dalmazi G; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U Mol Metab; 2018 Aug; 14():82-94. PubMed ID: 29935920 [TBL] [Abstract][Full Text] [Related]
13. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Kupka RW; Luckenbaugh DA; Post RM; Suppes T; Altshuler LL; Keck PE; Frye MA; Denicoff KD; Grunze H; Leverich GS; McElroy SL; Walden J; Nolen WA Am J Psychiatry; 2005 Jul; 162(7):1273-80. PubMed ID: 15994709 [TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. Perugi G; Akiskal HS; Micheli C; Toni C; Madaro D J Affect Disord; 2001 Dec; 67(1-3):105-14. PubMed ID: 11869757 [TBL] [Abstract][Full Text] [Related]
15. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients. Pai AY; Wenziger C; Streja E; Argueta DA; DiPatrizio NV; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D; Moradi H Am J Nephrol; 2021; 52(1):59-68. PubMed ID: 33601382 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP). Inoue T; Inagaki Y; Kimura T; Shirakawa O J Affect Disord; 2015 Mar; 174():535-41. PubMed ID: 25556671 [TBL] [Abstract][Full Text] [Related]
18. The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample. Perugi G; Toni C; Maremmani I; Tusini G; Ramacciotti S; Madia A; Fornaro M; Akiskal HS J Affect Disord; 2012 Jan; 136(1-2):e41-e49. PubMed ID: 20129674 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder. Dodd S; Kulkarni J; Berk L; Ng F; Fitzgerald PB; de Castella AR; Filia S; Filia K; Montgomery W; Kelin K; Smith M; Brnabic A; Berk M J Affect Disord; 2010 Jul; 124(1-2):22-8. PubMed ID: 19944466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]